sciphermedicine.comHealthcare / BioTech & PharmaFounded: 2015Funding to Date: $467.52MM
Scipher Medicine, founded in 2015, is a precision medicine platform focusing on analyzing patients' molecular data. Their mission is to enhance the accuracy of prescriptions and therapies, thereby tailoring medical treatments to individual patients' needs. By leveraging the power of molecular data, Scipher Medicine strives to optimize therapeutic outcomes and reduce the trial-and-error nature of traditional prescribing. Scipher Medicine is headquartered in Waltham, Massachusetts.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
02/24/2022 | Series D | $120.72MM | $xx.xx | $498.65MM | Cowen Healthcare Investments, Neuberger Berman, Hitachi Ventures, Laurion Capital, Monashee Investment Management, Northpond Ventures, aMoon, Khosla Ventures, Optum Ventures, Echo Health Ventures, Alumni Ventures | |
Price per Share
$xx.xx
Shares Outstanding
3,166,980
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Cowen Healthcare Investments, Neuberger Berman, Hitachi Ventures, Laurion Capital, Monashee Investment Management, Northpond Ventures, aMoon, Khosla Ventures, Optum Ventures, Echo Health Ventures, Alumni Ventures
|
||||||
03/25/2021 | Series C | $82MM | $xx.xx | $256.76MM | aMoon, Northpond Ventures, Echo Health Ventures, Khosla Ventures, Alumni Ventures | |
Price per Share
$xx.xx
Shares Outstanding
2,806,379
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
aMoon, Northpond Ventures, Echo Health Ventures, Khosla Ventures, Alumni Ventures
|
||||||
02/19/2020 | Series B | $25MM | $xx.xx | $95.96MM | Optum Ventures | |
Price per Share
$xx.xx
Shares Outstanding
1,452,417
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Optum Ventures
|
||||||
09/06/2018 | Series A | $9.42MM | $xx.xx | $29.32MM | Khosla Ventures | |
Price per Share
$xx.xx
Shares Outstanding
1,216,331
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Khosla Ventures
|
||||||
10/20/2016 | Series Seed | $1.62MM | $xx.xx | $5.4MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
676,128
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
|